Showing results (41-50 of 1,519) with videos related to

Sort By:
Pageof 152
CPT: Pharmacometrics & Systems Pharmacology|December 23, 2024
Development of a physiologically-based pharmacokinetic model for Ritonavir characterizing exposure and drug interaction potential at both acute and steady-state conditionsLien Thi Ngo, Woojin Jung, Tham Thi Bui, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 16, 2024
Physiologically based pharmacokinetic modeling and simulation of topiramate in populations with renal and hepatic impairment and considerations for drug-drug interactionsShuqing Chen, Chaozhuang Shen, Yuchen Tian, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 21, 2024
Population pharmacokinetics of selexipag for dose selection and confirmation in pediatric patients with pulmonary arterial hypertensionLene Nygaard Axelsen, Anne Kümmel, Juan Jose Perez Ruixo, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 24, 2025
Toward Precision Dosing of Lamotrigine During Pregnancy: Physiologically Based Pharmacokinetic Modeling and SimulationYudie Qian, Wanhong Wu, Chengjie Ke, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 6, 2024
Pharmacometric and statistical considerations for dose optimizationPalang Chotsiri, Prasert Yodsawat, Richard M Hoglund, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 5, 2024
Informing pregnancy dose via target-mediated drug disposition modeling and simulations for a recombinant human monoclonal antibodyCourtney Moc Willeford, Krithika Shetty, Douglas Sheridan, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 5, 2024
Pharmacokinetic/pharmacodynamic analysis of geographic atrophy lesion area in patients receiving pegcetacoplan treatment or shamRyan L Crass, Komal Prem, Francois Gaudreault, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 2, 2025
Population Pharmacokinetic Analysis of Datopotamab Deruxtecan (Dato-DXd), a TROP2-Directed Antibody-Drug Conjugate, in Patients With Advanced Solid TumorsYing Hong, Sophie Peigné, Υuzhuo Pan, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 30, 2025
A Model-Based Meta-Analysis of Pembrolizumab Effects on Patient-Reported Quality of Life: Advancing Patient-Centered Oncology Drug DevelopmentYiqin Zou, Yimeng Sun, Sudhamshu Ravva, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 24, 2025
An Open-Source Framework for Virtual Bioequivalence Modeling and Clinical Trial DesignAbdullah Hamadeh, Moriah Pellowe, Pierre Chelle, et al.
Pageof 152